Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study

by Karolina Akinosoglou, Christos Savopoulos, Abraham Pouliakis, Charalampos Triantafyllidis, Eleftherios Markatis, Foteini Golemi, Angelos Liontos, Charikleia Vadala, Ilias C. Papanikolaou, Vasiliki Dimakopoulou, Panagiotis Xarras, Katerina Varela, Georgia Kaiafa, Athanasios Mitsianis, Anastasia Chatzistamati, Efthalia Randou, Spyridon Savvanis, Maria Pavlaki, Georgios Efraimidis, Vasileios Samaras, Dimitrios Papazoglou, Alexandra Konstantinidou, Periklis Panagopoulos, Haralampos Milionis, on behalf of the INTERACT Study Group
Published 2022-04-01